Filter
558
Text search:
experimental
drug
Featured
Recommendations
43
New Publications
93
Language
Document type
No document type
302
Studies & Reports
112
Guidelines
76
Manuals
34
Strategic & Response Plan
11
Training Material
7
Fact sheets
7
Situation Updates
5
Resource Platforms
4
Countries / Regions
India
25
Global
23
Western and Central Europe
15
Latin America and the Carribbean
14
Kenya
11
South Africa
10
Ethiopia
9
Rwanda
9
Sierra Leone
7
Tanzania
7
Uganda
6
Ukraine
6
Liberia
5
Nigeria
5
Germany
5
Bangladesh
5
Brazil
5
Eastern Europe
5
Ghana
4
Zimbabwe
4
Nepal
4
South Sudan
4
Africa
4
Russia
4
Congo, Democratic Republic of
3
USA
3
Philippines
3
Malawi
3
Argentina
3
Colombia
3
Myanmar / Burma
3
South–East Asia Region
3
Burkina Faso
2
Cameroon
2
Haiti
2
Zambia
2
Indonesia
2
Eswatini/ Swaziland
2
Lesotho
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Venezuela
2
Tajikistan
2
Guinea
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Syria
1
Thailand
1
China
1
Mozambique
1
Namibia
1
Peru
1
Botswana
1
Yemen
1
Paraguay
1
Asia
1
Canada
1
Uzbekistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
56
Public Health
36
Women & Child Health
12
Key Resources
12
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
Mental Health
98
NTDs
46
TB
42
HIV
40
COVID-19
39
Ebola & Marburg
32
Pharmacy
20
AMR
19
Rapid Response
18
Caregiver
16
Planetary Health
11
NCDs
11
Malaria
11
Disability
10
2.0 Rapid Response
8
Global Health Education
6
Zika
4
Health Financing Toolbox
4
Conflict
3
Refugee
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr
...
The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authorisation drug Remdesivir. For this reason, Joint
Mo
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
World Drug Report 2018
-3-
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
World Drug Report 2018
-5-
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse
...
Perspectives on Drugs
A Mini Review of Antiparasitic Agents explored between 2010-2021. Frontiers in Chemistry 9:771143
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
Journal of Computational Biophysics and ChemistryVol. 22, No. 01, pp. 31-41 (2023)